Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06651671 · ClinicalTrials.gov registry record · NA

Tissue Changes Following Thoracic Myofascial Release

A NA study, sponsored by Rowan University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT06651671 is a NA study that has completed, run by Rowan University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06651671, a NA study, has completed, sponsored by Rowan University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Brief Summary: The goal of this clinical trial is to determine the efficacy of myofascial release in altering the parameters of muscle tone, stiffness, and viscoelasticity in young adults. The main questions it aims to answer are: What is the efficacy of myofascial release in altering muscle tone, stiffness, and viscoelasticity? What is the efficacy of light hands-on sham as a control? Are there differences in these parameters between men and women? What is the reliability of MyotonPro use in young adults? Researchers will randomly allocate and compare the treatment group, which receives osteopathic manipulative medicine (OMM) in the form of 30 seconds of indirect myofascial release followed by 30 seconds of direct myofascial release, to the control group, which receives 1 minute of light hands-on traps placebo, to see if there are differences in muscle tone, stiffness, and viscoelasticity.

Interventions

  • PROCEDURE Sham (No Treatment)
  • PROCEDURE Myofascial release

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-03-30
Est. Completion 2023-07-31
Phase NA

Sponsor

Rowan University

19 total trials

What the Registry Record Tells You About NCT06651671

The ClinicalTrials.gov registry entry for NCT06651671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rowan University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham (No Treatment) is the first listed.

NCT06651671 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06651671 about?

NCT06651671 is a clinical study titled "Tissue Changes Following Thoracic Myofascial Release". Brief Summary: The goal of this clinical trial is to determine the efficacy of myofascial release in altering the parameters of muscle tone, stiffness, and viscoelasticity in young adults. The main questions it aims to answer are: What is the efficacy of myofascial release in altering muscle tone,...

What is the current status of trial NCT06651671?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-03-30. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT06651671?

The interventions under investigation include: Sham (No Treatment) (PROCEDURE), Myofascial release (PROCEDURE).

Who is sponsoring clinical trial NCT06651671?

This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.